We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




X chromosome Genes Linked to Male Infertility

By LabMedica International staff writers
Posted on 12 Jul 2022

Male infertility can be caused by low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. More...

Illnesses, injuries, chronic health problems, lifestyle choices and other factors may contribute to male infertility.

Although the evolutionary history of the X chromosome indicates its specialization in male fitness, its role in spermatogenesis has largely been unexplored. Currently only three X chromosome genes are considered of moderate-definitive diagnostic value.

A large international team of medical scientists led by the University of Florence (Florence, Italy) used targeted X chromosome sequencing or exome sequencing to search for genetic contributors to infertility in more than 2,350 men with idiopathic forms of non-obstructive azoospermia or cryptozoospermia that could not be explained using conventional diagnostic methods. Genomic data were analyzed and compared with data in normozoospermic control individuals and Genome Aggregation Database (gnomAD) database (Broad Institute, Cambridge, MA, USA).

The team flagged hundreds of X chromosome genes that were recurrently mutated in men with infertility. When they whittled that set down by considering associations within and across cohorts, they identified 21 genes with the strongest spermatogenic ties and another 34 genes with more modest associations. When the team took the most pronounced infertility associations forward for targeted sequence analyses in another 265 men with non-obstructive azoospermia/cryptozoospermia and 54 non-obstructive azoospermia patients, it identified nine infertile men carrying variants in half a dozen of the genes. Still other genes in the candidate set had weaker links to infertility across the replication cohort.

The investigators validated suspected associations, explored protein interaction profiles for candidate infertility contributors, and searched for other genes that had higher-than-usual mutation burdens in infertile men compared with their fertile counterparts. The most frequently affected prioritized gene, RBBP7, was found mutated in ten men across all cohorts.

Csilla Krausz, MD, PhD, an Endocrinologist and a senior author of the study, said, “Our analysis represents a substantial step toward reducing the gap in our understanding of X-linked genetic causes of spermatogenic failure.”

The authors concluded that collectively, their study represents a significant step towards the definition of the missing genetic etiology in idiopathic severe spermatogenic failure and significantly reduces the knowledge gap of X-linked genetic causes of azoospermia contributing to the development of future diagnostic gene panels. The study was published on July 8, 2022 in the American Journal of Human Genetics.

Related Links:
University of Florence 
Genome Aggregation Database


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.